CLASSYS continues to recruit and develop world-class talent while\u00a0bolstering\u00a0its capabilities across technology, business and global operations to support its global\u00a0expansion. The appointment of Dr. Taek-Soo Kim as CTO reflects the company’s commitment to strengthening its global technology leadership and preparing for its next phase of growth. <\/p>\n
Last month, CLASSYS launched its “Next Stage” growth strategy with the appointment of Jun-oh Yoon, former Executive Vice President of Samsung Electronics, as its Chief Executive Officer (CEO). With Dr. Kim joining to execute that strategy within the R&D organization, the company plans to accelerate technological innovation and the development of next-generation products centered on AI, software, and data. <\/p>\n
After graduating from Seoul Science High School, Dr. Kim earned a bachelor’s degree in Electrical Engineering from Seoul National University, followed by a master’s degree from the University of Southern California (USC) and a Ph.D. from Stanford University, both in Electrical Engineering. During his doctoral studies\u00a0at Stanford, he specialized in medical imaging technologies, particularly signal processing for magnetic resonance imaging (MRI),\u00a0building\u00a0technical\u00a0expertise in medical device technology. <\/p>\n
He\u00a0subsequently served as a consultant at Boston Consulting Group (BCG), a group head at Samsung Advanced Institute of Technology (SAIT), and Chief Strategy Officer (CSO) at medical AI company Vuno, driving technology strategy, R&D process innovation, global partnerships, and the commercialization of medical AI solutions. Through these roles, he accumulated comprehensive experience spanning technology development, clinical application, regulatory approval, and commercialization. <\/p>\n
Dr. Kim’s appointment is viewed as a key step toward realizing CEO Jun-oh Yoon’s vision of making CLASSYS the world’s leading medical aesthetics technology platform company with $1 billion in revenue by 2030. In his inaugural address, CEO Yoon expressed his commitment to transforming CLASSYS from a traditional device manufacturer into a global medical aesthetics technology company offering next-generation products and services built on AI, software, and data. <\/p>\n
Dr. Kim plans to combine CLASSYS’s established energy-based device (EBD) technologies with its extensive clinical and procedural data, applying AI to drive development of next-generation products designed to reshape the market. In particular, he will systematically incorporate feedback from clinicians and key opinion leaders (KOLs) across major global markets into the R&D process. This approach will enhance treatment efficacy, usability, safety, and the overall user experience, enabling CLASSYS to lead the global market with differentiated medical aesthetics technologies and solutions that meet market and customer expectations. <\/p>\n
Furthermore, Dr. Kim’s track record of leading large-scale R&D transformation initiatives at leading global technology organizations is expected to accelerate the implementation of CEO Yoon’s global-standard management systems across the R&D organization. Through rigorous risk management and agile execution, CLASSYS will continue building a more agile and efficient R&D culture. <\/p>\n
A CLASSYS spokesperson said, “While CEO Jun-oh Yoon combined an engineer’s deep technical expertise with a strategist’s global perspective to help drive Samsung’s growth, CTO Taek-Soo Kim helped lead R&D transformation and technology innovation at Samsung Advanced Institute of Technology (SAIT), the company’s premier advanced research organization. Together, their strengths are expected to help CLASSYS redefine the global medical aesthetics industry and establish itself as a top-tier global company.” <\/p>\n